75
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Cardiac response to pharmacological stress in heart failure reduced and heart failure preserved ejection fraction

, , &
Received 30 Nov 2023, Accepted 21 Apr 2024, Published online: 03 May 2024

References

  • Verbrugge FH, Guazzi M, Testani JM, et al. Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney. Circulation. 2020;142(10):998–1012. doi: 10.1161/CIRCULATIONAHA.119.045409.
  • Claeys M, Petit T, La Gerche A, et al. Impaired biventricular contractile reserve in patients with diastolic dysfunction: insights from exercise stress echocardiography. Eur Heart J Cardiovasc Imaging. 2022;23(8):1042–1052. doi: 10.1093/ehjci/jeac041.
  • Asrar Ul Haq M, Goh CY, Levinger I, et al. Clinical utility of exercise training in heart failure with reduced and preserved ejection fraction. Clin Med Insights Cardiol. 2015;9:1–9. doi: 10.4137/CMC.S21372.
  • Nayor M, Houstis NE, Namasivayam M, et al. Impaired exercise tolerance in heart failure with preserved ejection fraction: quantification of multiorgan system reserve capacity. JACC Heart Fail. 2020;8(8):605–617. doi: 10.1016/j.jchf.2020.03.008.
  • Bhella PS, Prasad A, Heinicke K, et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(12):1296–1304. doi: 10.1093/eurjhf/hfr133.
  • Olsson LG, Swedberg K, Clark AL, et al. Six-minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J. 2005;26(8):778–793. doi: 10.1093/eurheartj/ehi162.
  • Ng AC, Sitges M, Pham PN, et al. Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography. Am Heart J. 2009;158(5):836–844. doi: 10.1016/j.ahj.2009.09.010.
  • Aggeli C, Lagoudakou S, Felekos I, et al. Two-dimensional speckle tracking for the assessment of coronary artery disease during dobutamine stress echo: clinical tool or merely research method. Cardiovasc Ultrasound. 2015;13(1):43. doi: 10.1186/s12947-015-0038-z.
  • McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368.
  • Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(2):101–138. doi: 10.1016/j.echo.2016.10.016.
  • Kane GC, Hepinstall MJ, Kidd GM, et al. Safety of stress echocardiography supervised by registered nurses: results of a 2-year audit of 15,404 patients. J Am Soc Echocardiogr. 2008;21(4):337–341. doi: 10.1016/j.echo.2007.08.028.
  • Pellikka PA, Nagueh SF, Elhendy AA, et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20(9):1021–1041. doi: 10.1016/j.echo.2007.07.003.
  • Ruffolo RR, Jr., Spradlin TA, Pollock GD, et al. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther. 1981;219(2):447–452.
  • Kieu A, Shaikh A, Kaeppler M, et al. Patients with hypertensive responses to exercise or dobutamine stress testing differ in resting hypertensive phenotype. J Am Soc Hypertens. 2018;12(2):108–116. doi: 10.1016/j.jash.2017.12.004.
  • Pratali L, Picano E, Otasevic P, et al. Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol. 2001;88(12):1374–1378. doi: 10.1016/s0002-9149(01)02116-6.
  • Egstrup M, Gustafsson I, Andersen MJ, et al. Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: comparison of echocardiographic and invasive measurements. Eur Heart J Cardiovasc Imaging. 2013;14(7):659–667. doi: 10.1093/ehjci/jes234.
  • Marmor A, Schneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol. 1997;29(2):422–428. doi: 10.1016/s0735-1097(96)00493-7.
  • Park JH, Woo JS, Ju S, et al. Layer-specific analysis of dobutamine stress echocardiography for the evaluation of coronary artery disease. Medicine . 2016;95(32):e4549. doi: 10.1097/MD.0000000000004549.
  • Ahmad T, Miller PE, McCullough M, et al. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. Eur J Heart Fail. 2019;21(9):1064–1078. doi: 10.1002/ejhf.1557.
  • Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90. doi: 10.1161/CIRCULATIONAHA.116.021884.
  • Sweeney M, Corden B, Cook SA. Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? EMBO Mol Med. 2020;12(10):e10865. doi: 10.15252/emmm.201910865.
  • Simmonds SJ, Cuijpers I, Heymans S, et al. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding. Cells. 2020;9(1):242. doi: 10.3390/cells9010242.
  • de Boer RA, De Keulenaer G, Bauersachs J, et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the committee of translational research of the Heart Failure Association (HFA) of the European Society of Cardiology. Eur J Heart Fail. 2019;21(3):272–285. doi: 10.1002/ejhf.1406.
  • Sinning D, Kasner M, Westermann D, et al. Increased left ventricular stiffness impairs exercise capacity in patients with heart failure symptoms despite normal left ventricular ejection fraction. Cardiol Res Pract. 2011;2011:692862. doi: 10.4061/2011/692862.
  • Bytyçi I, D'Agostino A, Bajraktari G, et al. Left atrial stiffness predicts cardiac events in patients with heart failure and reduced ejection fraction: the impact of diabetes. Clin Physiol Funct Imaging. 2021;41(2):208–216. doi: 10.1111/cpf.12688.
  • Bytyci I, Dini FL, Bajraktari A, et al. Speckle tracking-derived left atrial stiffness predicts clinical outcome in heart failure patients with reduced to mid-range ejection fraction. J Clin Med. 2020;9(5):1244.
  • Westermann D, Kasner M, Steendijk P, et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation. 2008;117(16):2051–2060. doi: 10.1161/CIRCULATIONAHA.107.716886.
  • Flesch M, Schwinger RH, Schiffer F, et al. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation. 1996;94(5):992–1002. doi: 10.1161/01.cir.94.5.992.
  • Nagueh SF, Shah G, Wu Y, et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation. 2004;110(2):155–162. doi: 10.1161/01.CIR.0000135591.37759.AF.
  • Govind SC, Gopal AS, Netyö A, et al. Quantification of low-dose dobutamine stress using speckle tracking echocardiography in coronary artery disease. Eur J Echocardiogr. 2009;10(5):607–612. doi: 10.1093/ejechocard/jep011.
  • Leitman M, Balboul Y, Burgsdorf O, et al. Myocardial work index during normal dobutamine stress echocardiography. Sci Rep. 2022;12(1):6813. doi: 10.1038/s41598-022-10903-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.